Send feedback

CPT1C p.Met798Val

c.2392A>G · rs113511313 · VCV542770

Benign/Likely benign Multiple submitters
Classification
Benign/Likely benign
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 4 submitters
AlphaMissense
likely benign
0.054 · ACMG-weighted
gnomAD v4.1
Rare
rare (popmax 0.41%, nfe)
Missense predictors
0/3 damaging
AlphaMissense, REVEL, SaProt
Conditions
1
hereditary spastic paraplegia 73

Computational evidence

Protein change
AlphaMissense0.054likely benign
REVEL0.132moderately benign-leaning
SaProtLLR -5.05tolerated
⇒ AlphaMissense, REVEL and SaProt all call this tolerated.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP -0.15
Regional constrainto/e 0.87unconstrained · MANE · 4,824 bp · p 0.0093 · regional, not allelic
Overall
CADD0.332PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.41% European (non-Finnish) · 4,836/1,179,104 alleles
Filtering AF 0.4% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.396%
Overall 0.346% 5,581/1,612,116 alleles · rare
Ancestry group Frequency 1 in
Finnishnot grpmax-eligible 0.414% 241
European (non-Finnish)grpmax 0.41% 244
Remaining individualsnot grpmax-eligible 0.348% 288
South Asian 0.168% 594
African / African-American 0.0867% 1,154
Admixed American 0.0723% 1,384
Middle Eastern 0.0166% 6,040
Ashkenazi Jewishnot grpmax-eligible 0.0034% 29,422

Finnish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
CPT1C
Protein
p.Met798Val
Coding
c.2392A>G
MANE Select
NM_001199753
dbSNP
rs113511313
Type
single nucleotide variant
Location
chr19:49713585 (GRCh38)
Gene constraint
LOEUF 0.778 · pLI <0.01 (gnomAD)
Structure
AlphaFold pLDDT 88.81 · 1 PDB
Residue 798
the 'required for interaction with gria1' region; the 'disordered' region
Full CPT1C gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

hereditary spastic paraplegia 73 — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

For Autosomal dominant spastic paraplegia type 73 (Orphanet):

Inheritance
Autosomal dominant
Onset
Adult

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/cpt1c-p-met798val (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown